Your browser doesn't support javascript.
loading
Treatment of beta-thalassemia with Bushen Yisui therapy: a randomized controlled trial / 中西医结合学报
Journal of Integrative Medicine ; (12): 137-40, 2007.
Article Dans Chinois | WPRIM | ID: wpr-449517
ABSTRACT

OBJECTIVE:

To investigate the efficacy and safety of Yisui Shengxue Granule (YSSXG), a compound traditional Chinese herbal medicine, in treating beta-thalassemia.

METHODS:

A randomized single-blinded trial was designed. Sixty patients with beta-thalassemia were divided into two groups 30 patients in YSSXG-treated group and 30 in placebo parallel-control group. The patients in the two groups were assigned to receive either YSSXG or placebo for three months. The patients' symptoms and their blood indexes such as hemoglobin (Hb), red blood cell (RBC), reticulocytes (Ret) and fetal hemoglobin (HBF) were examined before and after the treatment. Meanwhile, the liver and spleen were examined with B-mode ultrasound.

RESULTS:

In the YSSXG-treated group, the blood indexes (Hb, RBC, Ret and HBF) and the symptoms of the patients were improved after three-month treatment, with statistical significance compared to those before treatment (P0.05).

CONCLUSION:

YSSXG demonstrates obvious clinical efficacy and no adverse reactions in treating beta-thalassemia.
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Essai clinique contrôlé langue: Chinois Texte intégral: Journal of Integrative Medicine Année: 2007 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Essai clinique contrôlé langue: Chinois Texte intégral: Journal of Integrative Medicine Année: 2007 Type: Article